GlassScriptPhysician profile
Aradhana Kar
NPI 1447358692
$8,163.29
in general payments reported to CMS, 2019-2025
35 companies · $1,371 in 2025
The $1,371 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,944 · 2020: $509 · 2021: $551 · 2022: $524 · 2023: $1,073 · 2024: $2,192 · 2025: $1,371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,635.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,028.50 | 2019-2025 | |
| Pfizer INC. | $805.81 | 2019-2025 | |
| Glaxosmithkline, LLC. | $713.84 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $684.14 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $581.05 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $496.27 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $431.10 | 2019-2025 | Jardiance |
| Teva Pharmaceuticals USA, INC. | $322.97 | 2019-2020 | |
| Amgen INC. | $305.64 | 2019-2025 | Repatha, Otezla, Krystexxa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $247.40 | 2019-2024 | Xifaxan |
| Mylan Specialty L.P. | $197.26 | 2019-2024 | Yupelri |
| Exact Sciences Corporation | $156.90 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $122.16 | 2019 | |
| Sunovion Pharmaceuticals INC. | $116.15 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $108.59 | 2019-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $106.88 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $88.87 | 2019 | |
| Amarin Pharma, INC. | $87.63 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $75.01 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $65.63 | 2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $43.59 | 2023-2024 | |
| Astellas Pharma US INC | $42.40 | 2020 | |
| Genentech USA, INC. | $40.41 | 2019 | |
| Philips North America LLC | $40.00 | 2019 | |
| Edwards Lifesciences Corporation | $33.35 | 2025 | Sapien 3 Ultra Resilia |
| Seqirus USA INC | $31.74 | 2019-2020 | |
| Horizon Therapeutics Plc | $26.55 | 2023 | Krystexxa |
| Becton, Dickinson and Company | $23.98 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.22 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.17 | 2019 | |
| Ibsa Pharma INC. | $21.85 | 2025 | Licart, Flector, Tirosint |
| Organon LLC | $21.71 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $20.37 | 2021 | |
| Bausch Health US, LLC | $18.22 | 2019 | |
| Sanofi Pasteur INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aradhana Kar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.